Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2
Open Access
- 15 October 2003
- journal article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 12 (4) , 321-332
- https://doi.org/10.1038/sj.ejhg.5201101
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- Analysis of the RNASEL Gene in Familial and Sporadic Prostate CancerAmerican Journal of Human Genetics, 2002
- Germline Alterations of the RNASEL Gene, a Candidate HPC1 Gene at 1q25, in Patients and Families with Prostate CancerAmerican Journal of Human Genetics, 2002
- Germline mutations in the ribonuclease L gene in families showing linkage with HPC1Nature Genetics, 2002
- HPC2 Variants and Screen-Detected Prostate CancerAmerican Journal of Human Genetics, 2001
- Evaluation of Linkage and Association of HPC2/ELAC2 in Patients with Familial or Sporadic Prostate CancerAmerican Journal of Human Genetics, 2001
- A candidate prostate cancer susceptibility gene at chromosome 17pNature Genetics, 2001
- Association of HPC2/ELAC2 Genotypes and Prostate CancerAmerican Journal of Human Genetics, 2000
- International trends and patterns of prostate cancer incidence and mortalityInternational Journal of Cancer, 2000
- Racial Differences in a Prostate Cancer Screening StudyJournal of Urology, 1996